BIVDA are holding a combined Infectious Diseases and Near Patient Testing Working Party on Thursday 14th May 2026 between 10:30 - 13:00. You can register here and find a full agenda below.
Ben KempApril 29, 2026
The renewed Women's Health Strategy for England was released by the Department of Health earlier this month setting out how the government intends to improve women's health and healthcare over the next 10 years. This strategic document has been much anticipated with standout points on easier access to care and reducing waiting times, support for more access to address unmet…
Ben KempApril 29, 2026
Tuesday 5th May, 2pm - 3pm Led by Sarah Joy Newton, Director of Amethyst Connect, this session will focus on the some of the key changes in NHS tenders over recent years and what members need to be aware of in preparation for bidding in 2026. The mandatory requirements for suppliers and the additional supporting scoring questions in NHSSC tenders…
Ben KempApril 29, 2026
Helen attended Biosecurity Security Frontiers and Innovation Forum which examined the acute prospective biosecurity risks facing the UK and how innovations can mitigate these issues. The event, attended by Health Innovation Minister Zubir Ahmed MP, focused on three challenges: Biodetection and Biosurveillance; AI and Diagnostics, Therapeutics and Vaccines; and PPE. Given the inevitability of future pandemics, a current unstable global…
Ben KempApril 28, 2026
The MHRA are hosting a live Ask Me Anything on Wednesday 20 May 2026 at 9:30am – 10:30am on how artificial intelligence (AI) is being regulated in healthcare. This is your opportunity to hear directly from the National AI Commission and ask questions about what this means for you. Register now and submit your questions in advance. This helps the…
Ben KempApril 28, 2026
The MHRA have extended their fee waiver programme for UK micro and small enterprises developing innovative medical devices. The updated programme will run from 20 April 2026 to 5 April 2027, following evaluation of the initial pilot. Based on feedback, they have introduced two key changes: The programme now includes some Class III medical devices The MHRA will now review…
Ben KempApril 28, 2026
The Institute of Directors (IoD) is bringing together leaders from across the Health & Life Sciences sector to launch their newest Special Interest Group. 📅 6 May 2026 ⌚ 6:30–8:30pm 📍 Cafe Duke, 116 Pall Mall George Freeman MP, Dr Annalisa Jenkins OBE, and Chris Molloy will feature as guest speakers, and attendees will have the opportunity to connect with…
Ben KempApril 28, 2026
BIVDA's Policy and Public Affairs Executive Ben Kemp attended a Health and Life Sciences Showcase event in Parliament hosted by Curia, UKAI and UKHLSI. The event sought to highlight health companies with highly innovative products, including BIVDA member Genomics. It was attended by innovators, NHS leaders, and parliamentarians, the latter including sponsoring MP Steve Yemm and former Chair of the…
Ben KempApril 28, 2026
BIVDA Chief Executive Helen Dent has had her article, 'Pass the Baton: Why NHS Innovation Stalls at the Finish Line', published in Chamber UK journal, read by parliamentarians across both Houses. In the article, Helen observed that, despite widespread agreement across industry, the NHS and government on what needs to change, progress remains limited. She noted that while experts have…
Ben KempApril 28, 2026
BIVDA was pleased to host the Department of Business and Trade (DBT) and Office for Life Sciences (OLS) last week as they presented on what the UK-India Free Trade Agreement (FTA) means for life sciences companies. Set to take effect in early July, the FTA will open up UK businesses to £38bn in Indian public procurement. Of particular interest to…
Ben KempApril 28, 2026